Squarekids (DPT-IPV) / Sanofi - LARVOL DELTA

Daiichi exits combo vaccine pact with Sanofi after pertussis shot manufacturing glitches (Fierce Pharma) - "Daiichi Sankyo is axing its marketing pact with Sanofi for its Squarekids combination vaccine and terminating a development deal for the pentavalent combination shot VN-0105 after encountering a manufacturing glitch....Daiichi added that it will stop distributing the product from March 31....Daiichi also said it would continue to work with Sanofi on the production and supply of other drugs, including vaccines....The Japanese drugmaker will compensate Sanofi to the tune of 15 billion yen ($135.41 million), with plans to record the loss in the fourth quarter of its 2020 fiscal year..."

Licensing / partnership • Infectious Disease • Pertussis